Corticosteroid therapy in patients with severe sepsis and septic shock

Seminars in Respiratory and Critical Care Medicine

Volumn 25, Issue 6, 2004, Pages 713-719

  Keh, Didier ^a   Goodman, Serge ^b   Sprung, Charles L ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Adrenal insufficiency; Corticosteroids; Low dose hydrocortisone; Sepsis; Septic shock

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; FLUDROCORTISONE; GAMMA INTERFERON; HLA DR ANTIGEN; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ADRENAL INSUFFICIENCY; ANTIINFLAMMATORY ACTIVITY; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; DRUG MEGADOSE; ESCHERICHIA COLI; HEMODYNAMICS; HUMAN; IMMUNOMODULATION; INFECTION RISK; LOW DRUG DOSE; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SHORT COURSE THERAPY; SYSTEMATIC REVIEW;

EID: 11144317893     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-860985     Document Type: Review

References (70)

1. Meduri GU. An historical review of glucocorticoid treatment in sepsis: disease pathophysiology and the design of treatment investigation. Sepsis 1999;3:21-38
2. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebo-controlled trials. N Engl J Med 1988;319:964-971
3. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-1531
4. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-1556
5. Hoffman SL, Punjabi NH, Kumala S, et al. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone. N Engl J Med 1984;310:82-88
6. Meduri GU, Chinn AJ, Leeper KV, et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome. Chest 1994;105:1516-1527
7. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280:159-165
8. Montaner JS, Lawson LM, Levitt N, Belzberg A, Schechter MT, Ruedy J. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990;113:14-20
9. Gagnon S, Boota AM, Fischl MA, Baier H, Kirksey OW, La Voie L. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a double-blind, placebo-controlled trial. N Engl J Med 1990;323:1444-1450
10. Oelkers W. Adrenal insufficiency. N Engl J Med 1996;335:1206-1212
11. Annane D, Briegel J, Sprung CL. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348:2157-2159
12. Brigham KL, Bowers RE, McKeen CR. Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J Clin Invest 1981;67:1103-1110
13. Hinshaw LB. Development of animal models for application to clinical trials in septic shock. Prog Clin Biol Res 1989;308:835-846
14. Hinshaw LB, Archer LT, Beller-Todd BK, et al. Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res 1980;28:151-170
15. Hinshaw LB, Beller BK, Archer LT, Flournoy DJ, White GL, Phillips RW. Recovery from lethal Escherichia coli shock in dogs. Surg Gynecol Obstet 1979;149:545-553
16. Hinshaw LB, Beller-Todd BK, Archer LT, et al. Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli. Ann Surg 1981;194:51-56
17. Barnes PJ. Anti-inflammatory mechanisms of glucocorticoids. Biochem Soc Trans 1995;23:940-945
18. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-1362
19. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21:55-89
20. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976;184:333-341
21. Sprung CL, Caralis PV, Marcial EH, et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study. N Engl J Med 1984;311:1137-1143
22. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23:1294-1303
23. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23:1430-1439
24. Slotman GJ, Fisher CJ Jr, Bone RC, Clemmer TP, Metz CA. Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1993;21:191-195
25. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348:727-734
26. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med 2003;31:141-145
27. Annane D, Cavaillon JM. Corticosteroids in sepsis: from bench to bedside? Shock 2003;20:197-207
28. Beishuizen A, Thijs LG, Vermes I. Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001;27:1584-1591
29. Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002;165:983-991
30. Molijn GJ, Spek JJ, van Uffelen JC, et al. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononudear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab 1995;80:1799-1803
31. Matot I, Sprung CL. Corticosteroids in septic shock: resurrection of the last rites? Crit Care Med 1998;26:627-629
32. Bouachour G, Tirot P, Gouello JP, Mathieu E, Vincent JF, Alquier P. Adrenocortical function during septic shock. Intensive Care Med 1995;21:57-62
33. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002;122:1784-1796
34. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A three-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-1045
35. Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991;337:582-583
36. Moran JL, Chapman MJ, OqFathartaigh MS, Peisach AR, Pannall PR, Leppard P. Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 1994;20:489-495
37. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998;26:645-650
38. Oppert M, Reinicke A, Graf KJ, Barckow D, Frei U, Eckardt KU. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 2000;26:1747-1755
39. Perla D, Marmorston J. Suprarenal cortical hormone and salt in the treatment of pneumonia and other severe infections. Endocrinology 1940;27:367-374
40. Walker BR, Williams BC. Corticosteroids and vascular tone: mapping the messenger maze. Clin Sci (London) 1992;82:597-605
41. Ullian ME. The role of corticosteriods in the regulation of vascular tone. Cardiovasc Res 1999;41:55-64
42. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990;87:10043-10047
43. Keh D, Boehnke T, Weber-Carstens S, et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, cross-over study. Am J Respir Crit Care Med 2003;167:512-520
44. Heller AR, Heller SC, Borkenstein A, Stehr SN, Koch T. Modulation of host defense by hydrocortisone in stress doses during endotoxemia. Intensive Care Med 2003;29:1456-1463
45. Lösel RM, Feuring M, Falkenstein E, Wehling M. Nongenomic effects of aldosterone: cellular aspects and clinical implications. Steroids 2002;67:493-498
46. Wehling M, Spes CH, Win N, et al. Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 1998;83:3517-3522
47. Briegel J, Kellermann W, Forst H, et al. Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group. Clin Investig 1994;72:782-787
48. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-871
49. Chawla K, Kupfer Y, Goldman I, Tessler S. Hydrocortisone reverses refractory septic shock [abstract]. Crit Care Med 1999;27:A33
50. Yildiz O, Doganay M, Aygen B, Guven M, Keleutimur F, Tutuu A. Physiological-dose steroid therapy in sepsis. Crit Care 2002;6:251-259
51. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27:723-732
52. Huettemann E, Bernhardt A, Schelenz C, Reinhart K. Low dose hydrocortisone does not influence myocardial function in patients with septic shock [abstract]. Intensive Care Med 2003;29:S154
53. Annane D, Bellissant E, Sebille V, et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998;46:589-597
54. Meduri GU, Kanangat S, Bronze M, et al. Effects of methylprednisolone on intracellular bacterial growth. Clin Diagn Lab Immunol 2001;8:1156-1163
55. Galon J, Franchimont D, Hiroi N, et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002;16:61-71
56. Schelling G, Briegel J, Roozendaal B, Stoll C, Rothenhausler HB, Kapfhammer HP. The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors. Biol Psychiatry 2001;50:978-985
57. Rubenfeld GD. When survival is not the same as mortality. Critical Care Alert 2003;10:113-115
58. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating severe sepsis and septic shock. Cochrane Database Syst Rev 2004;(1):CD002243
59. Van Den Berghe G, Wouters P, Weckers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367
60. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288:2859-2867
61. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348:683-693
62. Tunn S, Pappert G, Willnow P, Krieg M. Multicentre evaluation of an enzyme-immunoassay for cortisol determination. J Clin Chem Clin Biochem 1990;28:929-935
63. Miller AH, Pariante CM, Pearce BD. Effects of cytokines on glucocorticoid receptor expression and function: glucocorticoid resistance and relevance to depression. Adv Exp Med Biol 1999;461:107-116
64. Dökmetas HS, Colak R, Kelestimur F, Selcuklu A, Unluhizarci K, Bayram F. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 2000; 85:3713-3719
65. Zarkovic M, Ciric J, Stojanovic M, et al. Optimizing the diagnostic criteria for standard (250-microg) and low dose (1-microg) adrenocorticotropin tests in the assessment of adrenal function. J Clin Endocrinol Metab 1999;84:3170-3173
66. Siraux V, De Backer D, Melot C, et al. High vers. low dose ACTH stimulation tests to assess adrenal function in patients with septic shock [abstract]. Intensive Care Med 2002;28: S75
67. Mayenknecht J, Diederich S, Bahr V, Plockinger U, Oelkers W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998;83:1558-1562
68. Siraux V, De Backer D, Yalavatti GS, et al. Methologic aspects of low and standard dose ACTH stimulation tests in patients with septic shock [abstract]. Intensive Care Med 2002;28:S75
69. Rolih CA, Ober KP. The endocrine response to critical illness. Med Clin North Am 1995;79:211-224
70. Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003;361:1881-1893